• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-455 基因敲除小鼠表现出记忆缺陷和焦虑增加,靶向阿尔茨海默病相关关键基因。

The microRNA-455 Null Mouse Has Memory Deficit and Increased Anxiety, Targeting Key Genes Involved in Alzheimer's Disease.

机构信息

School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.

出版信息

Int J Mol Sci. 2022 Jan 5;23(1):554. doi: 10.3390/ijms23010554.

DOI:10.3390/ijms23010554
PMID:35008980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8745123/
Abstract

The complete molecular mechanisms underlying the pathophysiology of Alzheimer's disease (AD) remain to be elucidated. Recently, microRNA-455-3p has been identified as a circulating biomarker of early AD, with increased expression in post-mortem brain tissue of AD patients. MicroRNA-455-3p also directly targets and down-regulates APP, with the overexpression of miR-455-3p suppressing its toxic effects. Here, we show that miR-455-3p expression decreases with age in the brains of wild-type mice. We generated a miR-455 null mouse utilising CRISPR-Cas9 to explore its function further. Loss of miR-455 resulted in increased weight gain, potentially indicative of metabolic disturbances. Furthermore, performance on the novel object recognition task diminished significantly in miR-455 null mice ( = 0.004), indicating deficits in recognition memory. A slight increase in anxiety was also captured on the open field test. and were identified as new direct targets for miR-455-3p, with overexpression of miR-455-3p leading to a reduction in the expression of , and in neuroblastoma cells. In the hippocampus of miR-455 null mice at 14 months of age, the levels of protein for APP, BACE1 and TAU were all increased. Such findings reinforce the involvement of miR-455 in AD progression and demonstrate its action on cognitive performance.

摘要

阿尔茨海默病(AD)病理生理学的完整分子机制仍有待阐明。最近,miR-455-3p 被确定为 AD 的早期循环生物标志物,AD 患者死后脑组织中的表达增加。miR-455-3p 还直接靶向并下调 APP,miR-455-3p 的过表达抑制其毒性作用。在这里,我们表明 miR-455-3p 在野生型小鼠大脑中的表达随年龄增长而降低。我们利用 CRISPR-Cas9 生成了 miR-455 缺失的小鼠,以进一步探索其功能。miR-455 的缺失导致体重增加,可能表明存在代谢紊乱。此外,miR-455 缺失小鼠在新物体识别任务中的表现显著下降(=0.004),表明识别记忆受损。在旷场试验中也捕捉到了轻微的焦虑增加。和被鉴定为 miR-455-3p 的新直接靶标,miR-455-3p 的过表达导致神经母细胞瘤细胞中表达的减少。在 14 个月大的 miR-455 缺失小鼠的海马体中,APP、BACE1 和 TAU 的蛋白水平均升高。这些发现强化了 miR-455 参与 AD 进展的作用,并证明了其对认知表现的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/71c8786e1bee/ijms-23-00554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/97108a8fcf4f/ijms-23-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/8c9ae5cc73a9/ijms-23-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/f200624552d3/ijms-23-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/71c8786e1bee/ijms-23-00554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/97108a8fcf4f/ijms-23-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/8c9ae5cc73a9/ijms-23-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/f200624552d3/ijms-23-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/8745123/71c8786e1bee/ijms-23-00554-g004.jpg

相似文献

1
The microRNA-455 Null Mouse Has Memory Deficit and Increased Anxiety, Targeting Key Genes Involved in Alzheimer's Disease.miR-455 基因敲除小鼠表现出记忆缺陷和焦虑增加,靶向阿尔茨海默病相关关键基因。
Int J Mol Sci. 2022 Jan 5;23(1):554. doi: 10.3390/ijms23010554.
2
Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.下调表达的 microRNA-338-5p 导致阿尔茨海默病的神经病理学改变。
FASEB J. 2019 Mar;33(3):4404-4417. doi: 10.1096/fj.201801846R. Epub 2018 Dec 21.
3
Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中,通过抑制2-花生四烯酸甘油(2-AG)代谢实现的突触和认知改善是通过上调微小RNA-188-3p来实现的。
J Neurosci. 2014 Nov 5;34(45):14919-33. doi: 10.1523/JNEUROSCI.1165-14.2014.
4
miR-186 is decreased in aged brain and suppresses BACE1 expression.miR-186在衰老大脑中表达降低,并抑制β-分泌酶1(BACE1)的表达。
J Neurochem. 2016 May;137(3):436-45. doi: 10.1111/jnc.13507. Epub 2016 Mar 30.
5
MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.微小 RNA-339-5p 下调人原代脑培养物中β-淀粉样前体蛋白裂解酶 1(BACE1)的蛋白表达,并在阿尔茨海默病患者脑组织标本中减少。
J Biol Chem. 2014 Feb 21;289(8):5184-98. doi: 10.1074/jbc.M113.518241. Epub 2013 Dec 18.
6
MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.微小RNA-361-3p通过靶向β-分泌酶1抑制阿尔茨海默病中的β-淀粉样蛋白积累并减轻认知缺陷。
J Integr Neurosci. 2019 Sep 30;18(3):285-291. doi: 10.31083/j.jin.2019.03.1136.
7
MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.MicroRNA-195 通过靶向 BACE1 下调阿尔茨海默病淀粉样β的产生。
Brain Res Bull. 2012 Sep 1;88(6):596-601. doi: 10.1016/j.brainresbull.2012.05.018. Epub 2012 Jun 19.
8
MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.微小 RNA-132-3p 通过下调稳定的 HNRNPU 的 BACE1 减轻阿尔茨海默病中的神经元凋亡和学习记忆能力损伤。
Cell Cycle. 2021 Nov;20(21):2309-2320. doi: 10.1080/15384101.2021.1982507. Epub 2021 Sep 29.
9
Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease.循环微小细胞外囊泡衍生的 miR-342-5p 通过靶向阿尔茨海默病中的β-淀粉样前体蛋白裂解酶 1 改善β-淀粉样形成。
Cells. 2022 Nov 29;11(23):3830. doi: 10.3390/cells11233830.
10
MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.MicroRNA-384 调节淀粉样前体蛋白和β-分泌酶的表达,是阿尔茨海默病的潜在生物标志物。
Int J Mol Med. 2014 Jul;34(1):160-6. doi: 10.3892/ijmm.2014.1780. Epub 2014 May 13.

引用本文的文献

1
The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer's Disease.脂肪干细胞分泌的LEFTY2在治疗阿尔茨海默病中的治疗潜力
Int J Mol Sci. 2025 Apr 4;26(7):3382. doi: 10.3390/ijms26073382.
2
The microRNA-455 null mouse shows dysregulated bone turnover.微小RNA - 455基因敲除小鼠表现出骨转换失调。
JBMR Plus. 2025 Jan 12;9(3):ziaf007. doi: 10.1093/jbmrpl/ziaf007. eCollection 2025 Mar.
3
miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.在前列腺癌患者的外周血中,miR-455-3p 具有比前列腺特异性抗原(PSA)更高的诊断潜力。

本文引用的文献

1
Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide.微生物组相关甲基胺对血脑屏障完整性的调节作用和氧化三甲胺对认知的影响。
Microbiome. 2021 Nov 27;9(1):235. doi: 10.1186/s40168-021-01181-z.
2
APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE-TR mice.载脂蛋白 E4 基因型加剧了绝经对 APOE-TR 小鼠认知和突触可塑性的影响。
FASEB J. 2021 May;35(5):e21583. doi: 10.1096/fj.202002621RR.
3
Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.
PLoS One. 2025 Feb 14;20(2):e0317385. doi: 10.1371/journal.pone.0317385. eCollection 2025.
4
Circulating small RNAs shed new light on dementia risk.循环小RNA为痴呆风险带来新线索。
Alzheimers Dement. 2025 Feb;21(2):e14546. doi: 10.1002/alz.14546. Epub 2025 Jan 27.
5
MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease.miRNA-455-3P 作为轻度认知障碍和阿尔茨海默病的外周生物标志物和治疗靶点。
Ageing Res Rev. 2024 Sep;100:102459. doi: 10.1016/j.arr.2024.102459. Epub 2024 Aug 15.
6
Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology.揭示轻度行为障碍的潜在机制:聚焦淀粉样蛋白和tau 病理学。
Cells. 2024 Jul 8;13(13):1164. doi: 10.3390/cells13131164.
7
Neural Correlates and Molecular Mechanisms of Memory and Learning.记忆与学习的神经关联与分子机制。
Int J Mol Sci. 2024 Feb 27;25(5):2724. doi: 10.3390/ijms25052724.
8
Emerging Translational Research in Neurological and Psychiatric Diseases: From In Vitro to In Vivo Models.神经和精神疾病新兴转化研究:从体外到体内模型。
Int J Mol Sci. 2023 Oct 30;24(21):15739. doi: 10.3390/ijms242115739.
9
The role of epigenetics in anxiety disorders.表观遗传学在焦虑障碍中的作用。
Mol Biol Rep. 2023 Nov;50(11):9625-9636. doi: 10.1007/s11033-023-08787-6. Epub 2023 Oct 7.
10
A state-of-the-art review on miRNA in prevention and treatment of Alzheimers disease.miRNA 在阿尔茨海默病防治中的研究进展
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Aug 25;52(4):485-498. doi: 10.3724/zdxbyxb-2023-0324.
假说:Tau 病理学是散发性阿尔茨海默病的起始因素。
Alzheimers Dement. 2021 Jan;17(1):115-124. doi: 10.1002/alz.12192. Epub 2020 Oct 19.
4
Differential Expression and miRNA-Gene Interactions in Early and Late Mild Cognitive Impairment.早期和晚期轻度认知障碍中的差异表达及miRNA-基因相互作用
Biology (Basel). 2020 Aug 28;9(9):251. doi: 10.3390/biology9090251.
5
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.微小 RNA 失调与神经退行性疾病中的线粒体功能障碍。
Int J Mol Sci. 2020 Aug 20;21(17):5986. doi: 10.3390/ijms21175986.
6
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.脑能量拯救:衰老相关神经退行性疾病的新兴治疗理念。
Nat Rev Drug Discov. 2020 Sep;19(9):609-633. doi: 10.1038/s41573-020-0072-x. Epub 2020 Jul 24.
7
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.探索神经退行性疾病的病因联系:炎症细胞因子和生物活性犬尿氨酸。
Int J Mol Sci. 2020 Mar 31;21(7):2431. doi: 10.3390/ijms21072431.
8
Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome.代谢综合征认知功能障碍和痴呆的发病机制途径。
Life Sci. 2019 Nov 15;237:116932. doi: 10.1016/j.lfs.2019.116932. Epub 2019 Oct 10.
9
MicroRNA-455-3p promotes TGF-β signaling and inhibits osteoarthritis development by directly targeting PAK2.微小 RNA-455-3p 通过直接靶向 PAK2 促进 TGF-β 信号通路并抑制骨关节炎的发展。
Exp Mol Med. 2019 Oct 4;51(10):1-13. doi: 10.1038/s12276-019-0322-3.
10
A New Discovery of MicroRNA-455-3p in Alzheimer's Disease.阿尔茨海默病中 microRNA-455-3p 的新发现。
J Alzheimers Dis. 2019;72(s1):S117-S130. doi: 10.3233/JAD-190583.